The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?

Multiparametric magnetic resonance imaging (mpMRI) has been increasingly utilized in the prostate cancer diagnostic landscape over the last five years. The majority of the literature has focused on its use in men with a previous negative biopsy. However, over time, clinicians have begun using mpMRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathianathen, Niranjan J., Warlick, Christopher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Sexual Medicine and Andrology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119840/
https://www.ncbi.nlm.nih.gov/pubmed/30168298
http://dx.doi.org/10.5534/wjmh.180025
_version_ 1783352143897427968
author Sathianathen, Niranjan J.
Warlick, Christopher A.
author_facet Sathianathen, Niranjan J.
Warlick, Christopher A.
author_sort Sathianathen, Niranjan J.
collection PubMed
description Multiparametric magnetic resonance imaging (mpMRI) has been increasingly utilized in the prostate cancer diagnostic landscape over the last five years. The majority of the literature has focused on its use in men with a previous negative biopsy. However, over time, clinicians have begun using mpMRI in the work-up of men being considered for primary biopsy and subsequently data characterizing its diagnostic performance in this setting is emerging. This review comprehensively assesses the utility of mpMRI in the primary biopsy setting.
format Online
Article
Text
id pubmed-6119840
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Society for Sexual Medicine and Andrology
record_format MEDLINE/PubMed
spelling pubmed-61198402018-09-10 The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime? Sathianathen, Niranjan J. Warlick, Christopher A. World J Mens Health Review Article Multiparametric magnetic resonance imaging (mpMRI) has been increasingly utilized in the prostate cancer diagnostic landscape over the last five years. The majority of the literature has focused on its use in men with a previous negative biopsy. However, over time, clinicians have begun using mpMRI in the work-up of men being considered for primary biopsy and subsequently data characterizing its diagnostic performance in this setting is emerging. This review comprehensively assesses the utility of mpMRI in the primary biopsy setting. Korean Society for Sexual Medicine and Andrology 2018-09 2017-08-30 /pmc/articles/PMC6119840/ /pubmed/30168298 http://dx.doi.org/10.5534/wjmh.180025 Text en Copyright © 2018 Korean Society for Sexual Medicine and Andrology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Sathianathen, Niranjan J.
Warlick, Christopher A.
The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
title The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
title_full The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
title_fullStr The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
title_full_unstemmed The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
title_short The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
title_sort use of magnetic resonance imaging in the prostate cancer primary diagnostic pathway: is it ready for primetime?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119840/
https://www.ncbi.nlm.nih.gov/pubmed/30168298
http://dx.doi.org/10.5534/wjmh.180025
work_keys_str_mv AT sathianathenniranjanj theuseofmagneticresonanceimagingintheprostatecancerprimarydiagnosticpathwayisitreadyforprimetime
AT warlickchristophera theuseofmagneticresonanceimagingintheprostatecancerprimarydiagnosticpathwayisitreadyforprimetime
AT sathianathenniranjanj useofmagneticresonanceimagingintheprostatecancerprimarydiagnosticpathwayisitreadyforprimetime
AT warlickchristophera useofmagneticresonanceimagingintheprostatecancerprimarydiagnosticpathwayisitreadyforprimetime

Ejemplares similares